Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclin D1 binding protein 1 (CCNDBP1) is a nuclear protein encoded by the CCNDBP1 gene located on chromosome 15. It was identified through its interaction with Grap2 and cyclin D1, and functions primarily as a **negative regulator of cell cycle progression** by inhibiting the cyclin-D1/CDK4 complex, which prevents phosphorylation of the retinoblastoma (RB1) protein and blocks E2F-dependent transcription[1][3]. CCNDBP1 may also act as a negative regulator of tissue-specific gene expression, including in the liver, and interacts with other transcriptional regulators such as helix-loop-helix protein E12[1][3]. While CCNDBP1 has roles in regulating cellular proliferation and transcription, it is not classified as a classic drug target (e.g., receptor, enzyme, transporter), and no currently approved drugs are known to directly interact with or target CCNDBP1[1][3][7]. It is studied for its cellular functions and its potential role in diseases associated with cell cycle dysregulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin D1 binding protein 1 (CCNDBP1).